Cargando…

Unaffected ex vivo clotting cascade by experimental hemostatic nanoparticles when introduced in the presence of recombinant tissue plasminogen activator

CONTEXT: Hemostatic nanoparticles (hNPs) have shown efficacy in decreasing intracerebral hemorrhage (ICH) in animal models and are suggested to be of use to counter tissue plasminogen activator (tPA)-induced acute ICH. AIMS: The objective of this study was to test the ability of an hNP preparation t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Beyer, Margaret, France, John, Nagaraja, Tavarekere N., Lavik, Erin B., Knight, Robert A., Lewandowski, Christopher A., Miller, Joseph B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2022
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10167850/ https://www.ncbi.nlm.nih.gov/pubmed/37181845 http://dx.doi.org/10.4103/bc.bc_45_22

Ejemplares similares

Clot Waveform Analysis for Hemostatic Abnormalities
por: Wada, Hideo, et al.
Publicado: (2023)

A novel ex vivo approach for measuring plasminogen activation upon established plasma clots
por: Palazzolo, Jason S., et al.
Publicado: (2022)

Clotting Mimicry from Robust Hemostatic Bandages Based on Self-Assembling Peptides
por: Hsu, Bryan B., et al.
Publicado: (2015)

Superhydrophobic hemostatic nanofiber composites for fast clotting and minimal adhesion
por: Li, Zhe, et al.
Publicado: (2019)

Tissue plasminogen activator-based clot busting: Controlled delivery approaches
por: El-Sherbiny, Ibrahim M., et al.
Publicado: (2014)

CoolClot, a novel hemostatic agent for controlling life-threatening arterial bleeding
por: Mortazavi, SMJ, et al.
Publicado: (2013)

Hemostatic Enhancement via Chitosan Is Independent of Classical Clotting Pathways—A Quantitative Study
por: Chen, Kuan-Yu, et al.
Publicado: (2020)

Fibrin clot structure remains unaffected in young, healthy individuals after transient exposure to diesel exhaust
por: Metassan, Sofian, et al.
Publicado: (2010)

Vascular occlusion in a previously unaffected territory after treatment with intravenous plasminogen activator: illustrative case
por: Sugie, Akira, et al.
Publicado: (2021)

Tissue plasminogen activator mediates deleterious complement cascade activation in stroke
por: Zhao, Xue-Jun, et al.
Publicado: (2017)

Intravenous Tissue Plasminogen Activator in Combination With Mechanical Thrombectomy: Clot Migration, Intracranial Bleeding, and the Impact of “Drip and Ship” on Effectiveness and Outcomes
por: Chang, Adam, et al.
Publicado: (2020)

Unaffected in Cambodia
por: Marya, A.
Publicado: (2020)

Synthesis and Characterization of Tissue Plasminogen Activator—Functionalized Superparamagnetic Iron Oxide Nanoparticles for Targeted Fibrin Clot Dissolution
por: Heid, Susanne, et al.
Publicado: (2017)

Group A Streptococcus-Induced Activation of Human Plasminogen Is Required for Keratinocyte Wound Retraction and Rapid Clot Dissolution
por: Vu, Henry M., et al.
Publicado: (2021)

Hemostatic Resuscitation
por: McMullin, N. R., et al.
Publicado: (2006)

Hemostatic Resuscitation
por: McMullin, N. R., et al.
Publicado: (2006)

Hemostatic, milk clotting and blood stain removal potential of cysteine proteases from Calotropis gigantea (L.) R. Br. Latex
por: Bindhu, Omana Sukumaran, et al.
Publicado: (2014)

Hemostatic nanoparticles increase survival, mitigate neuropathology and alleviate anxiety in a rodent blast trauma model
por: Hubbard, W. Brad, et al.
Publicado: (2018)

To Clot or Not to Clot: Is That the Question?
por: Favaloro, Emmanuel J.
Publicado: (2023)

Lp(a) is not associated with diabetes but affects fibrinolysis and clot structure ex vivo
por: Månsson, Marianne, et al.
Publicado: (2014)

Ex-vivo porcine organs with a circulation pump are effective for teaching hemostatic skills
por: Izawa, Yoshimitsu, et al.
Publicado: (2012)

Slounase, a Batroxobin Containing Activated Factor X Effectively Enhances Hemostatic Clot Formation and Reducing Bleeding in Hypocoagulant Conditions in Mice
por: Adili, Reheman, et al.
Publicado: (2021)

Evaluation of ex vivo melanogenic response to UVB, UVA, and visible light in facial melasma and unaffected adjacent skin()()
por: Alcantara, Giovana Piteri, et al.
Publicado: (2020)

Impact of Idarucizumab and Andexanet Alfa on DOAC Plasma Concentration and ClotPro(®) Clotting Time: An Ex Vivo Spiking Study in A Cohort of Trauma Patients
por: Oberladstätter, Daniel, et al.
Publicado: (2021)

The effects of QuikClot Combat Gauze on hemorrhage control in the presence of hemodilution and hypothermia
por: Johnson, Don, et al.
Publicado: (2014)

Comparison of Topical Hemostatic Agents in a Swine Model of Extremity Arterial Hemorrhage: BloodSTOP iX Battle Matrix vs. QuikClot Combat Gauze
por: Li, Huixi, et al.
Publicado: (2016)

Monitoring the Formation of Fibrin Clots as Part of the Coagulation Cascade Using Fluorescent Single-Walled Carbon Nanotubes
por: Gerstman, Efrat, et al.
Publicado: (2023)

A Clot Waveform Analysis of Thrombin Time Using a Small Amount of Thrombin Is Useful for Evaluating the Clotting Activity of Plasma Independent of the Presence of Emicizumab
por: Wada, Hideo, et al.
Publicado: (2022)

Reteplase Fc-fusions produced in N. benthamiana are able to dissolve blood clots ex vivo
por: Izadi, Shiva, et al.
Publicado: (2021)

Staphylocoagulase as a hemostatic agent.
por: Mojovic, B., et al.
Publicado: (1969)

Thrombin based gelatin matrix and fibrin sealant mediated clot formation in the presence of clopidogrel
por: Dwyer, Joseph F, et al.
Publicado: (2014)

Clot or Not?
por: Peretz-Larochelle, Maude, et al.
Publicado: (2018)

Uterine Hemostatics
por: Hicks, J. Braxton
Publicado: (1884)

Inclusion of unaffected sibs increases power in model-free linkage analysis of a behavioral trait
por: Plancoulaine, Sabine, et al.
Publicado: (2005)

Efficacy of the hemostatic device VasoSTAT and the study of hemostatic factor
por: Naganawa, Hirokazu, et al.
Publicado: (2021)

Terminal Phase Components of the Clotting Cascade in Patients with End-Stage Renal Disease Undergoing Hemodiafiltration or Hemodialysis Treatment
por: Pénzes, Krisztina, et al.
Publicado: (2020)

Long-sheath Introducer-assisted Revascularization (L-SHARE) Technique for Treating Large-vessel Occlusion by a Giant Clot
por: Yamamoto, Nobuaki, et al.
Publicado: (2022)

Gelsolin Induces Colorectal Tumor Cell Invasion via Modulation of the Urokinase-Type Plasminogen Activator Cascade
por: Zhuo, Jingli, et al.
Publicado: (2012)

Postprandial thermogenesis and substrate oxidation are unaffected by sleep restriction
por: Shechter, Ari, et al.
Publicado: (2013)

Assessment of blood clot formation and platelet receptor function ex vivo in patients with primary Sjögren's syndrome
por: Collins, K S, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_l5iqtaug81f7otdmps3gqbijmb